Ulinastatin suppresses lipopolysaccharide induced neuroinflammation through the downregulation of nuclear factor-κB in SD rat hippocampal astrocyte

Biochemical and Biophysical Research Communications

Volumn 458, Issue 4, 2015, Pages 763-770

  Li, Yuting ^a   Zhao, Lei ^a   Fu, Huiqun ^a   Wu, Yan ^b   Wang, Tianlong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Astroyte; Neuroinflammation; NF kB; Ulinastatin

Indexed keywords

BROXURIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; ULINASTATIN; ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IN VITRO STUDY; MTT ASSAY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; IMMUNOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; GLYCOPROTEINS; HIPPOCAMPUS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84925465418     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.155     Document Type: Article

References (30)

1. A.J. Nimmo, and R. Vink Recent patents in CNS drug discovery: the management of inflammation in the central nervous system recent patents on CNS Drug Discov. 4 2009 86 95
2. L. Qian, P.M. Flood, and J.S. Hong et al. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy J. Neural. Transm. 117 2010 971 979
3. Y. Dong et al. Benveniste EN immune function of astrocytes Glia 36 2 2001 180 190
4. N.A. Oberheim, S.A. Goldman, and M. Nedergaard Heterogeneity of astrocytic form and function Methods Mol. Biol. 814 2012 23 45
5. M.V. Sofroniew, and H.V. Vinters Astrocytes: biology and pathology Acta. Neuropathol. 119 2010 7 35
6. S.J. Hewett Interferon-gamma reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation J. Neuroimmunol. 94 1999 134 143
7. S.J. Hewett, J.A. Corbett, and M.L. McDaniel et al. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes Neurosci. Lett. 164 1993 229 232
8. M.E. Hamby, A.R. Gragnolati, and S.J. Hewett et al. TGF beta1 and TNF alpha potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2 Neurochem. Int. 52 2008 962 971
9. A. Olumayokun, and Olajide et al. Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine Evid. Based Complement. Altern. Med. 2013 2013 459723
10. B.M. Jonsson, K. Ohlsson, and M. Rosengren Radio immunological quantitation of the urinary trypsin inhibitor in normal blood and urine Biol. Chem. 370 1989 1157 1161
11. C.C. Chen, S.S. Wang, and F.Y. Lee Action of antiproteases on the inflammatory response in acute pancreatitis JOP 8 2007 488 494
12. N. Wang, X. Liu, and X. Zheng Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model Int. Immunopharmacol. 17 2013 799 807
13. D.M. Pizzurro, K. Dao, and L.G. Costa Diazinon and diazoxon impair the ability of astrocytes to foster neurite outgrowth in primary hippocampal neurons Toxicol. Appl. Pharmacol. 274 2014 372 382
14. S.T. Zhao, and L. Zhao Neuroprotective peptide humanin inhibits inflammatory response in astrocytes induced by lipopolysaccharide Neurochem. Res. 38 2013 581 588
15. P. Molor-Erdene, K. Okajima, and H. Isobe et al. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression Am. J. Physiol. Heart. Circ. Physiol. 288 2005 1265 1271
16. T. Saji Clinical utility of ulinastatin, urinary protease inhibitor in acute Kawasaki disease Nihon. Rinsho. 66 2008 343 348
17. P.J. Khandelwal, A.M. Herman, and C.E. Moussa Inflammation in the early stages of neurodegenerative pathology J. Neuroimmunol. 238 2011 1 11
18. B.A. Barres The mystery and magic of glia: a perspective on their roles in health and disease Neuron 60 2008 430 440
19. L.F. Eng, R.S. Ghirnikar, and Y.L. Lee Glial fibrillary acidic protein: GFAP-thirty-one years Neurochem. Res. 25 1999 1439 1451
20. M.V. Sofroniew Molecular dissection of reactive astrogliosis and glial scar formation Trends. Neurosci. 32 2009 638 647
21. A.M. Kostianovsky, L.M. Maier, and R.C. Anderson et al. Astrocytic regulation of human monocytic/microglial activation J. Immunol. 181 2008 5425 5432
22. M.V. Sofroniew et al. Molecular dissection of reactive astrogliosis and glial scar formation Trends. Neurosci. 32 2008 638 647
23. S.T. Lin, Y. Wang, and Y. Xue Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaB-alpha-NF-kappaB signaling Mol. Cell Biochem. 315 2008 41 49
24. M.A. Palladino, F.R. Bahjat, E.A. Theodorakis, and L.L. Moldawer Anti-TNF-α therapies: the next generation Nat. Rev. Drug. Discov. 2 2003 736 746
25. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park, and S.S. Lee Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation Mutat. Res. 480-481 2001 243 268
26. Y.H. Sung, and Mal-Soon Shin UTI suppresses lipopolysaccharide-induced prostaglandin E2 synthesis and nitric oxide production through the downregulation of NF-κB in BV2 mouse microglial cells Int. J. Mol. Med. 5 2013 1030 1036
27. H. Wang, X. Sun, F. Gao, B. Zhong, Y.H. Zhang, and Z. Sun Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNK-2 and NF-κB J. Exp. Clin. Cancer. Res. 31 2012 2
28. H. Wang, X. Sun, and F. Gao UTI attenuates seawater-induced acute lung injury by influencing the activities of nuclear factor-κB and its related inflammatory mediators J. Exp. Clin. Cancer. Res. 83 2012 335 343
29. P.A. Baeuerle, and D. Baltimore NF-κB: ten years after Cell 87 1996 13 20
30. E. Niederberger, and G. Geisslinger The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J. 22 2008 3432 3442